Also Known As:
1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane; AWD.pharma brand of talinolol; cordanum; talinolol acetate; talinolol benzoate; talinolol hydrochloride; talinolol monoacetate; talinolol monohydrochloride; talinolol mononitrate; talinolol monosalicylate; talinolol nitrate; talinolol oxalate; talinolol oxalate (2:1); talinolol salicylate; talinolol sulfate; talinolol sulfate (2:1); talinolol tartrate (2:1), L-(+)-isomer; talinolol tartrate, L-(+)-isomer; talinolol, (+-)-isomer; (+-)-N-cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)urea
Networked: 40 relevant articles (1 outcomes, 9 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results


1. Terhaag, B: 3 articles (02/2005 - 07/2000)
2. Zschiesche, Michael: 2 articles (09/2004 - 02/2002)
3. Siegmund, Werner: 2 articles (09/2004 - 02/2002)
4. Kroemer, Heyo K: 2 articles (09/2004 - 02/2002)
5. Oertel, R: 2 articles (02/2001 - 07/2000)
6. Nácher, Amparo: 1 article (10/2011)
7. Merino-Sanjuán, Matilde: 1 article (10/2011)
8. Merino, Virginia: 1 article (10/2011)
9. Jiménez-Torres, Nicolás Víctor: 1 article (10/2011)
10. Catalán-Latorre, Ana: 1 article (10/2011)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Body Weight (Weight, Body)
02/01/2002 - "Because talinolol is marketed as a racemate, we reevaluated the serum-concentration time profiles of talinolol of a previously published study with single intravenous (30 mg) and repeated oral talinolol (100 mg for 14 days) before and after comedication of rifampicin (600 mg per day for 9 days) in eight male healthy volunteers (age 22-26 years, body weight 67-84 kg) with respect to differences in the kinetic profiles of the two enantiomers S(-) talinolol and R(+) talinolol. "
07/01/2000 - "Pharmacokinetics of digoxin (0.5 mg orally), talinolol (30 mg intravenously and 100 mg orally), and digoxin plus talinolol orally, as well as digoxin plus talinolol intravenously, were assessed in five male and five female healthy volunteers (age range, 23 to 30 years; body weight, 60 to 95 kg) in a changeover study with at least a 7-day washout period. "
08/15/1982 - "It is reported on a severe talinolol intoxication of a 19-year-old female patient who on suicidal purpose had taken 1.25-1.5 g talinolol (cordanum) (= 25-30 mg/kg body weight). "
09/01/2004 - "To evaluate whether it also regulates the multidrug transporter proteins P-glycoprotein (P-gp) and multidrug resistance protein MRP2 in humans, duodenal expression of multidrug resistance gene MDR1 messenger ribonucleic acid (mRNA) and MRP2 mRNA, content of P-gp and MRP2, and disposition of the nonmetabolized P-gp substrate talinolol after intravenous (30 mg) and long-term oral administration (100 mg for 19 days) were assessed in 7 healthy subjects (age, 23-35 years; body weight, 64-93 kg) before and after comedication of carbamazepine (600 mg for 14-18 days). "
Order ALL the reference details at left...
3. Angina Pectoris
4. Malnutrition
5. Sinus Tachycardia

Related Drugs and Biologics

1. Nifedipine (Adalat)
2. hydrochlorothiazide-triamterene (Dyazide)
3. Captopril (Capoten)
4. Propranolol (Inderal)
5. Atenolol (Tenormin)
6. Saquinavir (Invirase)
7. Rifampin (Rifampicin)
8. Metaproterenol (Alupent)
9. Metoprolol (Lopressor)
10. Digoxin (Digitek)

Related Therapies and Procedures

1. Oral Administration
2. Intravenous Injections
3. Aftercare (After-Treatment)

blog comments powered by Disqus
for Hypertension,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 4828 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>